Cost of revenue decreased 97.6%
Cost of revenue changed -97.6% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cost of revenue changed -97.6% from the comparable as-filed period.
Net income changed +257.5% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Revenue changed -209.3% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Inventory changed -12.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Shares outstanding changed +0.1% from the comparable as-filed period. The change ranks at the 0th percentile of 8 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.